COVID-19

In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&amp;D Blueprint is organizing a consultation to identify vaccine research priorities to facilitate further contributions of vaccines to achieve improved control of the pandemic everywhere.
During this forthcoming consultation global experts will review the available evidence, enumerate knowledge gaps, and outline research priorities related to a pan-sarbecovirus vaccine. The objectives of the meeting are to:
<ul type="circle">
<li data-list="0" data-level="1">Review scientific advances and development approaches to enable the development of a pan-sarbecovirus vaccine</li>
<li data-list="0" data-level="1">Provide an overview of various candidate vaccines under development</li>
<li data-list="0" data-level="1">Outline novel approaches for evaluation of pan-sarbecovirus vaccines, including in the context of the different variants of concern</li>
</ul>
&nbsp;

Director-General

President & CEO

Director

Registration Required

World Health Organization (WHO)

English

Dr. Tedros Adhanom Ghebreyesus was appointed as the Director-General of the World Health Organization in 2017. Since then, Dr. Tedros has transformed the organization’s strategy and culture to achieve measurable impact in improving health outcomes around the world, as well as leading the ongoing WHO response to COVID-19. We have curated a list of virtual events featuring Dr. Tedros, so you can hear him speak from anywhere.

Dr. Tedros Adhanom Ghebreyesus was appointed as the Director-General of the World Health Organization in 2017. Since then, Dr. Tedros has transformed the organization&rsquo;s strategy and culture to achieve measurable impact in improving health outcomes around the world, as well as leading the ongoing WHO response to COVID-19. We have curated a list of virtual events featuring Dr. Tedros, so you can hear him speak from anywhere.

WHO consultation on COVID vaccines research: Why do we need a pan-sarbecovirus vaccine?

Share with friends